13 results
10-K
2021 FY
LIANY
LianBio
31 Mar 22
Annual report
8:55am
and security and transparency laws, such as the following:
federal healthcare program anti-kickback laws, which prohibit, among other things, persons from … , state transparency laws, state laws limiting interactions between pharmaceutical manufacturers and members of the healthcare industry, and state
10-Q/A
2021 Q3
LIANY
LianBio
10 Jan 22
Quarterly report (amended)
4:06pm
additional transparency about credit risk. The Company adopted ASU2016-13
in the third quarter of 2021 and applied the guidance prospectively … authorities to further promote transparency and certainty of policies and implementing measures,” it emphasized that it “has always been open
10-Q
2021 Q3
LIANY
LianBio
9 Dec 21
Quarterly report
5:24pm
Losses (“CECL”). CECL requires earlier recognition of credit losses on financial assets, while also providing additional transparency about credit risk … will continue to collaborate “closely with different stakeholders including investors, companies, and relevant authorities to further promote transparency
424B4
LIANY
LianBio
2 Nov 21
Prospectus supplement with pricing info
4:02pm
will continue to collaborate “closely with different stakeholders including investors, companies, and relevant authorities to further promote transparency … performed by a foreign public accounting firm completely. The proposed Ensuring Quality Information and Transparency for Abroad-Based Listings on our
S-1/A
005 a4cgq8z31
8 Oct 21
IPO registration (amended)
5:09pm
S-1
i3hap64lh g8rzjrzu
1 Oct 21
IPO registration
4:52pm
DRS/A
zf0e8ocps16pmp
21 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
4jyre mj45ifc69lr
2 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
vit8qv6 03xmlq
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
sbnn7cb l2
28 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next